home / stock / azn / azn articles

AZN Articles, AstraZeneca PLC - From 11/09/23

Stock Information
Company Name: AstraZeneca PLC
Stock Symbol: AZN
Market: NYSE
Website: astrazeneca.com
Menu
AZN AZN Quote AZN Short AZN News AZN Articles AZN Message Board
Get AZN Alerts

News, Short Squeeze, Breakout and More Instantly...
AstraZeneca Joins Anti-Obesity Race Dominated By Eli Lilly And Novo Nordisk, Reports Mixed Q3 Earnings | Benzinga

AstraZeneca Plc (NASDAQ: AZN) has reported Q3 FY23 core EPS of $1.73, up 4% Y/Y (+9% on constant currency). On the ADR basis, core e...
Wall Street To Snap Longest Winning Streak Since 2021 Today? Earnings, Bond Yields In Focus Ahead Of Powell's Speech | Benzinga

The stock market’s momentum appears to be waning, and futures suggest a mixed opening for Thursday. Earnings reports have generally been posi...

Price Over Earnings Overview: AstraZeneca | Benzinga

In the current market session, AstraZeneca Inc. (NASDAQ:AZN) share price is at $64.33, after a 0.58% increase. Moreover, over the past month, the s...

Why Is Cancer Player Cellectis Stock Trading Over 100% Higher Today? | Benzinga

Cellectis SA (NASDAQ: CLLS) shares are trading higher after the company announced a research agreement with AstraZeneca Plc&nbs...
Cellectis Announces Strategic Collaboration and Investment Agreements with AstraZeneca | Benzinga

Collaboration leverages Cellectis' gene editing technologies and manufacturing capabilities to develop up to 10 novel cell & gene therap...

Comparative Study: AstraZeneca And Industry Competitors In Pharmaceuticals Industry | Benzinga

In today's rapidly evolving and fiercely competitive business landscape, it is crucial for investors and industry analysts to conduct comprehe...

Merck Signs Multi-Billion Deal With Japan's Daiichi Sankyo For Cancer Therapy Drug Development | Benzinga

Merck & Company, Inc. (NYSE: MRK) and Japan's Daiichi Sankyo Co. Ltd. (OTC: DSKYF) entered into a global developme...
Why Is AstraZeneca Stock Trading Lower Today? | Benzinga

AstraZeneca Plc (NASDAQ: AZN) shares are trading lower after a data abstract on its experimental drug, datopotamab deruxtecan, for lung cancer...

United Airlines, Interactive Brokers And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session | Benzinga

U.S. stock futures traded lower this morning on Wednesday. Here are some big stocks recording losses in today’s pre-market trading session. ...

FDA Approves Merck's Top Selling Drug, Keytruda For Expanded Use In Lung Cancer Indication | Benzinga

The FDA approved Merck & Co Inc's (NYSE: MRK) Keytruda for resectable (tumors ≥4 centimeters [cm] or node-positive) non-small ...
Previous 10 Next 10